DUBLIN–( COMPANY CABLE)– The “Biopharmaceutical Agreement Advancement and Production Company Market Projection to 2033” has actually been contributed to ResearchAndMarkets.com’s offering. The worldwide biopharmaceutical agreement advancement and production company (CDMO) market is positioned to experience substantial development, with market dimension forecasts rising from USD 25.1 billion in 2024 to USD 56.6 billion by 2033, showing a CAGR of 9.55% in between 2025 and 2033. This market growth is driven by i.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/biopharmaceutical-cdmo-market-forecast-to-reach-56-5-billion-by-2033-demand-for-biologics-and-advanced-therapies-fuels-growth-at-a-9-55-cagr-researchandmarkets-com/
